Abstracts
Showing 14 abstracts.
Genotypic and Phenotypic Dolutegravir Resistance in Pregnant Women and Children Living with HIV-1
Conference
International Workshop on HIV Drug Resistance and Treatment Strategies
Study
IMPAACT 2010, P1093
Authors
TD Ruel, A Wiznia, S Lockman, L Chinula, PK Drain, GS Gottlieb, LM Frenkel, CL Boyce, RA Smith, R Nixon, MD Bishop, SM Styrchak, K Knowles, S BrummelA Single Once Daily ABC/DTG/3TC Tablet Predicts Safe and Effective Exposures in Children 3 to <6 kg
Conference
CROI 2024
Study
P1093, IMPAACT 2019
Authors
Marika Ciuffa, Michael McKenna, Andrew Wiznia, Sean Brummel, Adrie Bekker, Tim Cressey, Helena Rabie, Hardik Chandasana, Kristina Brooks, Ann M. Buchanan, Lionel Tan, Anna Turkova, Angela Colbers, Judy HopkingPROFICIENCY TESTING SUPPORTS COMBINED ANALYSIS OF DOLUTEGRAVIR PHARMACOKINETIC DATA
Conference
CROI 2019
Study
P1093
Authors
N van Ewijk, C Taylor, P Bollen, T Ruane, A Colbers, A Turkova, R Di Francesco, G Morse, R Browne, D Burger, E AcostaDolutegravir pharmacokinetics, safety and efficacy in HIV+ children 2 to <6 years old
Conference
CROI 2017
Study
P1093